NeoHx study: Perioperative treatment with trastuzumab in combination with capecitabine and oxaliplatin (XELOX-T) in patients with HER2 resectable stomach or esophagogastric junction (EGJ) adenocarcinoma—R0 resection, pCR, and toxicity analysis.
Fernando Rivera
Consultant or Advisory Role - Roche
Research Funding - Bayer; Roche
Paula Jiménez
No relevant relationships to disclose
Pilar Garcia Alfonso
No relevant relationships to disclose
Carlos Lopez
No relevant relationships to disclose
Javier Gallego
No relevant relationships to disclose
M. Luisa Limon
No relevant relationships to disclose
Maria Alsina
No relevant relationships to disclose
Luis Lopez-Gomez
No relevant relationships to disclose
Maica Galán
No relevant relationships to disclose
Esther Falco
No relevant relationships to disclose
Jose Luis Manzano
No relevant relationships to disclose
Encarnación González
No relevant relationships to disclose
Raquel Serrano
No relevant relationships to disclose
Eva Fernandez Parra
No relevant relationships to disclose
Monica Jorge
No relevant relationships to disclose